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WHAT THIS PAPER ADDS
 The article presents that endovascular surgery for abdominal aortic aneurysm (AAA) with massive neck atheroma tends to develop
late-phase complication, compared to open surgery. This is the ﬁrst report to analyse the complication after AAA operation in detail
(grades and time course) and relate it to cholesterol crystal embolism. Our deﬁnition of massive neck atheroma should be
acceptable under our conclusion, and it would be the springboard for the deﬁnition of the unclear term: ‘shaggy aorta’. Also, this
paper should inﬂuence the algorism of aortic aneurysm surgery, especially in case of shaggy aorta.a r t i c l e i n f o
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Objective: We retrospectively analysed surgically treated abdominal aortic aneurysm (AAA) in patients
with massive atheroma in the aneurysmal neck and compared the outcomes of endovascular aneurysm
repair (EVAR) and open surgery (OS) to determine an appropriate strategy for massive neck atheroma
cases.
Methods: A retrospective study was performed in 326 consecutive patients who underwent EVAR and in
247 patients who underwent OS. We deﬁned massive neck atheromas if the following characteristics
were observed: (1) thickness  5 mm; (2) the circumference of the infrarenal aorta  75%; and (3)
length  5 mm. Twenty-eight patients (8.5%) in the EVAR group and 22 (8.9%) in the OS group met these
criteria. We modiﬁed the previously published reporting standards on the basis of the selection of
systemic and embolisation-related complications.
Results: Patients in the EVAR group had less intra-operative blood loss, shorter operation time, and
shorter hospital stays after the operation (P < 0.01). No perioperative deaths were observed in either
group. Major complications were categorised as early (in-hospital) or late (outpatient, within 6 months).
Five and three patients in the OS and EVAR groups had early complications, but the difference was not
statistically signiﬁcant. In contrast, 7 patients in the EVAR group had late complications, compared to no
patients in the OS group (P ¼ 0.01). KaplaneMeier analysis revealed a signiﬁcantly higher survival rate in
the OS group (P¼ 0.011). Two of the 4 patients with suprarenal clamping developed major complications.
Mild eosinophilia was observed in 10 patients in the EVAR group. Proteinuria occurred or worsened in 5
EVAR patients and 1 OS patient.
Conclusion: Compared to OS patients, EVAR patients with massive neck atheroma tend to develop late-
phase complications possibly related to cholesterol crystal embolisation. The clinical features of massive
neck atheroma patients receiving EVAR should be carefully monitored even after hospital discharge.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Bunkyo-ku, Tokyo 113-8655,
ciety for Vascular Surgery. PublisheAlthough shaggy aorta is considered to be an atheromatous
aorta with a spiculated and irregular appearance, it has not been
deﬁned clearly.1 Aortic surgery for shaggy aorta via the open or
endovascular approach sometimes results in adverse events.1,2
Open surgery (OS) for patients with abdominal aortic aneurysmd by Elsevier Ltd. All rights reserved.
Table 1
Classiﬁcation and grades of complication severity.
Complication Grades
Deployment-related complication
Peripheral embolization 1 Resolution with embolectomy without
tissue loss
2 Minor tissue loss, including toe or
ray amputation
3 Major amputation or signiﬁcant tissue loss
Access site (wound) infection 1 Resolved with oral antibiotics
2 Operative drainage, intravenous antibiotics
3 Major debridement or drainage with
laparotomy
Implant-related complication
Graft infection 1 Apparently resolved or controlled
with antibiotics
2 Graft removal with extraanatomic
or in situ repair
Limb occlusion 1 Resolved at primary procedure
2 Limited retroperitonetal repair
or thrombectomy
3 Bypass or conversion
Buttock/leg claudication/
ischaemia
1 Transient
2 Persistent but not disabling
3 Sufﬁciently disabling to necessitate
intervention
Systemic complication
Cardiac 1 Little or no haemodynamic consequence
2 Symptomatic necessitating intravenous
medication, percutaneous transluminal
coronary angioplasty. Stent therapy
3 Severe haemodynamic dysfunction
necessitating resuscitation, cardiac arrest,
or fatal outcome
Pulmonary 1 Prompt recovery with medical treatment
2 Prolonged hospitalization or intravenous
antibiotics
3 Prolonged intubation, tracheostomy,
deterioration in pulmonary dysfunction,
O2 dependence
4 or fatal outcome
Renal insufﬁciency 1 No dialysis
2 Temporary dialysis, prolonged
hospitalization, permanently reduced
renal function
3 Permanent dialysis, transplant,
or fatal outcome
Cerebrovascular 1 Temporary deﬁcit with recovery
within 24 h
2 Delayed recovery, infarct on CT or
magnetic resonance, permanent deﬁcit
with mild impairment
3 Severe impairment or fatal outcome
Deep vein thrombosis 1 Anticoagulation therapy, inferior
vena cava ﬁlter
2 Surgical or lytic therapy
Pulmonary embolism 1 Anticoagulation therapy, inferior
vena cava ﬁlter
2 Haemodynamic instability, endovascular
or surgical therapy, or fatal outcome
Coagulopathy 1 Transfusion therapy
2 Surgical intervention or fatal outcome
Bowel ischaemia 1 Recovered without invtervention
2 Recovered with intravenous antibiotics
or total parenteral nutirition
3 Bowel resection, or fatal outcome
Spinal cord ischaemia 1 Resolution within 24 h
2 Resolution within 1 month or minor
permanent deﬁcit, able to walk
without support
3 Major permanent deﬁcit
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ﬂushing of debris and suprarenal clamping to avoid atheromatous
embolisation. At present, OS for AAA patients has been replaced by
endovascular aneurysm repair (EVAR) after two large prospective
studies published in 2004 demonstrated excellent short-term
outcomes.3,4 In this endovascular era, there has been an increase
in the use of EVAR. However, we are concerned that this low-stress
technique is being used without carefully considering atheroma-
tous shower.
The infrarenal aneurysm neck is commonly the site at which
occlusion balloons are used for touch-up in EVAR procedures. If the
atheroma is squeezed and released from the neck, it can cause
shower embolisation. In contrast to OS, EVAR is performed in
a ‘closed space’ where atheromatous debris cannot be ﬂushed out.
Therefore, we focussed on massive neck atheroma and hypoth-
esised that it is correlated to postoperative outcomes after EVAR.
In this study, we retrospectively analysed AAA surgical cases
with massive atheroma in the aneurysmal neck and compared
outcomes between groups of patients treated by EVAR and OS. In
addition, we determined an appropriate strategy for massive neck
atheroma.
Patients and Methods
Two institutes participated in this study. From December 2006
to December 2009, 326 patients underwent EVAR at Morinomiya
Hospital (Osaka, Japan). Between January 2003 and November
2010, 247 consecutive patients underwent OS at The University of
Tokyo Hospital (Tokyo, Japan). These institutions collaborate in data
collection but have their own guidelines for procedure selection for
AAA. Most patients who were admitted at Morinomiya Hospital
underwent EVAR; the rate of EVAR among AAA operations was 95%.
By contrast, at The University of Tokyo Hospital, conventional OS
was the ﬁrst-line treatment for several decades until the EVAR
procedure was ﬁrst introduced in 2008. Thus, long-term follow-up
data were available retrospectively. The rate of the OS procedures
was still approximately 90% in this hospital.
The aneurysmal neck is deﬁned as an infrarenal aorta with
a normal diameter; it is therefore a suitable location for the prox-
imal landing of the stent graft. In this study, we included patients
with a neck length more than 10 mm. The inclusion criteria for
massive neck atheroma were as follows: (1) thickness 5 mm, (2)
circumference of the infrarenal neck 75% and (3) length 5 mm
(axial section). The exclusion criteria were as follows: (1) cases in
which contrast computed tomography (CT) was not performed, (2)
juxtarenal AAA cases requiring branch reconstruction and (3) cases
in which rupture occurred. Twenty-eight patients (8.5%) who
underwent EVAR at Morinomiya Hospital (EVAR group) and 22
patients (8.9%) who underwent OS at The University of Tokyo
Hospital satisﬁed the inclusion criteria. Follow-up examinations
were performed until March 2011 (EVAR group: 3e45 months
(median, 22 months); OS group: 4e96 months (median, 62
months)).
To evaluate postoperative complications, we referred to the
reporting standards of the Ad Hoc Committee for Standardized
Reporting Practices in Vascular Surgery of the Society for Vascular
Surgery/American Association for Vascular Surgery.5 From the list
of complications, we selected systemic and embolisation-related
complications to evaluate the short-term results. The standards
adopted three grades (1: mild, 2: moderate and 3: severe) for each
complication.5 We focussed on the major complications (grades 2
and 3) (Table 1).
Patient demographics, including age, sex, the maximal antero-
posterior aneurysm diameter, statin use, aspirin use and the rates
of massive atheroma in the thoracic aorta are shown in Table 2.Massive atheroma of the ‘thoracic’ aorta was deﬁned as an
atheroma with the following characteristics: (1) thickness 5 mm,
(2) circumference of the thoracic aorta 75% and (3) length
100 mm.
Table 3
outcomes of the EVAR and OS groups.
EVAR OS P-value
Perioperative
mortality
None None e
Early complication
(in-hospital)
3 cases 5 cases 0.68
Case 1 Renal (gr.2) Case 1 Renal (gr.2) e
Peripheral (gr.2) Cardiac (gr.2)
Bowel (gr.2)
Case 2 Renal (gr.2) Case 2 Spinal (gr.2)
Bowel (gr.2)
Case 3 Renal (gr.2) Case 3 Cardiac (gr.2)
Cardiac (gr.3) Case 4 Renal (gr.2)
Case 5 Bowel (gr.2)
Late complication
(outpatient
within 6 mo)
7 cases None 0.01
Case 1 Renal (gr.3) e e
Peripheral (gr.2)
Case 2 Renal (gr.3)
Bowel (gr.2)
Case 4 Bowel (gr.2)
Case 5 Bowel (gr.2)
Case 6 Renal (gr.2)
Case 7 Renal (gr.2)
Case 8 Renal (gr.2)
gr: grades; Renal: Renal insufﬁciency; Peripheral: Peripheral embolization; Bowel:
Bowel ischaemia; Spinal: Spinal cord ischaemia.
Table 4
Details of complications in the EVAR group. Two cases (case 1 and 2) had initial and
continuous worsening of complications and were counted twice.
Early complication Late complication
Case 1 Cr level got worse to 2.5
Blue toe syndrome
Permanent dialysis
Blue toe syndrome got worse
Case 2 Cr level got worse to 2.5
Ischaemic colitis
(severe diarrhoea)
Permanent dialysis
Ischaemic colitis (remission
and progression)
Case 3 Temporary dialysis
Acute myocardial infarction
Case 4 Ischaemic colitis
(severe diarrhoea and fever)
Case 5 Ischaemic colitis
(severe diarrhoea and fever)
Case 6 Cr level got worse to 2.2
Case 7 Cr level got worse to 3.0
Case 8 Cr level got worse to 2.7
Table 2
Basic demographics and preoperative characteristics of the EVAR and the OS groups.
Variables EVAR (n ¼ 28) OS (n ¼ 22) P-value
Age 75.8  6.3 74.7  8.0 0.60
Sex (male:female) 27:1 19:3 0.19
Aneurysmal diameter
(antero-posterior)(mm) 51.5  9.8 54.2  10.8 0.36
Massive thoracic atheroma 8/28 2/22 0.11
Aspirin use 8/28 7/22 0.80
Statin use 10/28 4/22 0.17
Co-morbidities
Elder age (>80) 8/28 7/22 0.80
Hypertension 17/28 16/22 0.37
Diabetes Mellitus 4/26 6/22 0.25
Ischemic heart disease 5/28 11/22 0.01
Cerebrovascular disease 4/28 3/22 0.94
Chronic kidney disease 5/28 3/22 0.68
Glasgow aneurysm score 80.9  9.6 81.4  10.4 0.42
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hypertension, diabetes mellitus, ischaemic heart disease, cerebro-
vascular disease and chronic kidney disease as well as the Glasgow
Aneurysm Score (GAS) are shown in Table 2. The GAS is one of the
most useful methods for predicting the prognosis of patients who
undergo OS; it is deﬁned by the following equation:
GAS ¼ age þ (17 for shock) þ (7 for myocardial disease) þ (10 for
cerebrovascular disease) þ (14 for renal disease).6,7 Our deﬁnitions
of cardiac, cerebrovascular and renal diseases are the same as those
described by Samy.6
Two commercially available devices were used in this study:
a Gore Excluder AAA endoprosthesis (W.L. Gore and Associates,
Newark, DE, USA) and a Zenith endovascular graft (COOK Medical
Inc., Bloomington, IN, USA). The Excluder and Zenith were used in
17 and 11 patients, respectively. Regarding the neck anatomy, nine
patients did not meet the instructions for use of the devices (length
15 mm, neck angulation <60 and no severe calciﬁcation). None
of the 28 patients exhibited intra- or post-operative type I endo-
leaks. Touch-up using balloons for the proximal neck was per-
formed in all cases to prevent initial type I endoleaks. In the OS
procedures, straight and bifurcated graft replacements were per-
formed in six and 14 patients, respectively. Suprarenal clamping
was performed in four patients; the clamping times were 12, 24, 49
and 59 min in these patients.
The eosinophil blood count and urine protein, which indicate
one of the clinical aspects of cholesterol crystal embolism (CCE),
were examined at three time points: preoperatively, during the
hospital stay and within 6 months after discharge. The extent of
proteinuria was graded as , , 1þ, 2þ or 3þ.
Differences between the two groups were analysed using
unpaired Student’s t-tests. All-cause mortality was calculated using
the KaplaneMeier method. We used the log-rank test to detect
differences between the two groups. Values are reported as mean
(standard deviation (SD)). The level of signiﬁcance was set at
P < 0.05.
Results
The EVAR and OS groups were comparable with respect to age,
sex, and almost all co-morbidities (Table 2). There were signiﬁcant
baseline differences with respect to ischaemic heart disease and
short neck (P ¼ 0.01). GAS was not signiﬁcantly different between
these high-risk patient groups.
Patients in the EVAR group had signiﬁcantly less intra-operative
blood loss (EVAR vs. OS: 167ml [124] vs.1643ml [1181]; P< 0.001),
shorter operation times (173 min [61] vs. 272 min [79]; P < 0.001),and a shorter postoperative hospital stay (10.8 d [5.5] vs. 20.6 d
[9.6]; P < 0.001). No perioperative death (30-day mortality) or
secondary intervention occurred in either group during the follow-
up period.
Major complications (grades 2 and 3) were included in this
study and categorised as early (in-hospital) or late (outpatient,
within 6 months). In the OS and EVAR groups, ﬁve and three
patients exhibited early complications, respectively; however, the
difference was not signiﬁcant (P ¼ 0.68). By contrast, the EVAR
group had seven patients who developed late complications,
compared to 0 patients in the OS group (P ¼ 0.011; Table 3). Among
the seven patients with late complications, two had both initial and
continually worsening complications and were counted twice
(Table 4). Both cases with normal renal functions exhibited renal
deterioration leading to permanent dialysis. All ﬁve patients with
‘late’ renal complications had normal preoperative creatinine levels
(<1.0 mg dl1).
Among the ﬁve patients with early complications in the OS
group, suprarenal clamping was performed in two; the clamping
times were 24 and 59 min.
The patency of the inferior mesenteric artery (IMA) and bilateral
hypogastric arteries (HAs) was examined with postoperative
contrast CT scan and ultrasonography. IMA was excluded in all
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occlusion; intra-operative coil embolisationwas performed in three
patients, and the ipsilateral HA was originally occluded in one
patient. These four patients exhibited neither early nor late bowel
complications. In the OS group, one patient underwent IMA
reconstruction with bilateral HA ligature, and another patient
exhibited IMA and HAs occlusion; neither of these two patients had
any complications.
The overall survival rates of the EVAR and OS groups were
calculated using KaplaneMeier analysis. The EVAR group had
signiﬁcantly higher mortality than the OS group (P ¼ 0.011) (Fig. 1).
The causes of death varied widely: one due to thoraciceaortic
dissection; two sudden deaths; one gastric perforation; one
gastrointestinal bleeding; one remnant gastric cancer; two lung
cancers and one of unknown cause in the EVAR group. No direct
relationships between late-phase complications and the cause of
death were found. Meanwhile, one case of pneumonia and renal
failure each were detected in the OS group.
In the OS group, preoperative percutaneous coronary inter-
vention (PCI) was performed in six patients; no patients received
PCI in the EVAR group. Coronary artery bypass grafting was not
performed in either of the groups.
Mild blood eosinophilia (absolute eosinophil count,
600e1500 cells/ml)8 was not observed in the OS group but was
observed in 10 patients in the EVAR group; Three, six, and one
patients exhibited eosinophilia in hospital, after discharge, and
throughout the postoperative follow-up period. Neither moderate
nor severe eosinophilia (absolute eosinophil count >1500 cells/ml)
was detected in either group. Among the three EVAR patients with
early complications, only one exhibited eosinophilia after discharge
(Table 3). Among the seven EVAR patients with late complications,
the patients in cases 4 and 7 showed eosinophilia in-hospital; those
in cases 1 and 8 showed eosinophilia after discharge. Increases in
the urine protein levels were examined in patients for whom data
were available: one of 14 OS patients ( to 1þ) and ﬁve of 16 EVAR
patients (1þ to 3þ,  to 3þ,  to 3þ,  to 1þ,  to 3þ).
Discussion
Aortic surgery for shaggy aorta sometimes results in cata-
strophic shower embolisation. Endovascular procedures are
considered a contraindication for atheromatous aorta because the
catheter and other endovascular devices can extensively ‘rake off’
atheromatous debris.1,2,9 However, very little reliable evidence
supporting the use of EVAR for shaggy aorta has been obtained in
large-scale studies. Furthermore, shaggy aorta has not been deﬁned
clearly. In the present study, we deﬁned a shaggy aorta as
a “massive aortic atheromatous thrombus” (infrarenal neck and
thoracic aorta) and validated this deﬁnition. At present, the speciﬁcFigure 1. The KaplaneMeier curve shows superior overall survival in the OS group.
The log-rank test revealed a signiﬁcant difference between groups (P ¼ 0.011).roles of endovascular procedures are attracting increasing atten-
tion; thus, it is necessary to understand the risks of manipulation-
related embolisation. We limited the follow-up period to within 6
months after procedures to evaluate complications because causal
relationships between manipulations and complications become
less clear beyond this time.
Gitlitz et al. ﬁrst reported the use of EVAR in patients with
massive neck atheroma; they also conclude that the presence of
a neck atheromamay not necessarily be a contraindication to EVAR
because of the lack of primary endoleaks, migration and signiﬁcant
distal embolisation.10 However, two patients (10.5%; 2/19) exhibi-
ted embolisation; one asymptomatic renal infarction and one
asymptomatic embolisation of the tibial artery. Available records do
not detail the time courses of complications including renal func-
tion and ischaemic colitis whichmight be due to CCE; therefore, the
conclusion regarding the suitability of EVAR for shaggy aorta may
require further investigation.
Interestingly, late outcomes in our study were clearly different
between the two groups despite the fact that early outcomes were
similar. We intuitively recognised that late complications (which
are usually included in short-term results) might be affected by
inﬂammation due to CCE. Clinical features resulting from shower
embolisation varied including abnormal kidney function, cuta-
neous ﬁndings (e.g. livedo reticularis), blue toe syndrome and
gastrointestinal ischaemia. CCE is a facet of such showers11 and
might result in delayed clinical symptoms. Weeks or months may
pass before scattering and migration of cholesterol crystals induce
an endothelial inﬂammatory reaction leading to complete
obstruction.9,11
Nine of the 10 late complications in the present study occurred in
twoorgans; the kidneys and the bowel. Renal dysfunction is thought
to be caused by two main factors: nephrotoxicity in response to
contrast agents and nephropathy due to CCE. Contrast agents induce
renal vasoconstriction and interfere with water and sodium
absorption by the renal tubules; this leads to increased vascular
resistance and decreased glomerular ﬁltration rates.12 In cases of
chronic renal insufﬁciency, contrast agents are excreted at a slow
rate, which increases the risk of nephrotoxicity.13 By contrast,
massive crystals in the renal arterial tree exhibit a sub-acute time
course via an inﬂammatory reaction. They are difﬁcult to distin-
guish, which may be the reason why most studies ﬁnding adverse
events after AAA repair do not distinguish renal dysfunction types.
We hypothesise that the bowel ischaemia found in the present
series was derived from a CCE scenario rather than from simple
blood-ﬂow shortage. No HA-occluded cases (four, and two in the
EVAR and OS groups each) in this study exhibited bowel ischaemic
complications, which potentially supports our hypothesis.
However, ischaemic colitis itself results from the use of perioper-
ative antibiotics or haemodynamic realignment of colonic marginal
arteries. As in renal CCE, a deﬁnite diagnosis of colonic complica-
tions is difﬁcult tomake because it requires invasive organ biopsy.14
Since the onset of CCE is sometimes late and fatal, monitoring
clinical features even after hospital discharge and over-diagnosing
of CCE in EVAR patients with shaggy aorta should be performed.
For diagnostic methods less invasive than tissue biopsy, we
examined the laboratory data of eosinophil and urine protein.8,15
Among 29 patients in the EVAR group whose data were available,
10 patients (34%) exhibited mild eosinophilia, whichmight indicate
some inﬂammatory reaction after the catheter manoeuvre.
However, the time course of complications possibly related to CCE
did not coincide with eosinophilia. Therefore, eosinophil data is
only one of the non-speciﬁc prognostic factors for CCE complica-
tion. Similarly, proteinuria was more common in the EVAR group.
Although it is certain that proteinuria indicates deteriorating renal
function, it cannot be used as a very speciﬁc indicator of CCE.11
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categorise the shapes and properties of the atheromas. Normally,
a protruding atheroma is easily exfoliated bywiremanipulations. In
addition, a fragile atheroma, similar to a ‘soft’ carotid plaque, might
be present.16 A larger study is required to categorise the types of
atheromas; magnetic resonance imaging or intravenous ultraso-
nography may be useful for evaluating atheroma vulnerability.
In addition, massive atheroma in the thoracic aorta, which was
not signiﬁcantly different between groups (P ¼ 0.11) but probably
affected the co-morbidities in both groups, might affect shower
embolisation. In this study, it was difﬁcult to evaluate the effects of
thoracicmassive atheromawith the small number of patients. Five of
the eight patients in the EVAR group and none in the OS group had
postoperative complications.We cannot ignore the effects of the stiff
wire delivered up to thedescending thoracic aorta or arch in a typical
EVARmanoeuvre. However, we think that complete obstruction and
touch-up on the atheroma-rich aneurysmal neck is far more
hazardous than theeffect of thewiremovement in the thoracic aorta.
In conclusion, compared to OS patients, EVAR patients with
a massive neck atheroma tend to develop very late-phase compli-
cations perhaps related to CCE. OS should be the ﬁrst-line treatment
for massive atheroma because of its better outcomes than EVAR.
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